TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: proportion of patients with more than 1 point exacerbation in the INCAT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pinprick sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Immunization test result - IgA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: T-lymphocyte number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: MUAC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjects' compliance to treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of patients with positive ctDNA result
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: platelet aggregation activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: biochemical markers in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Area under curve (AUC) of TMC207
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signs or symptoms of toxicity ranked Grade 2 or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Negative Social Reactions
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Validation of the CPOT tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sustained virological response 12 weeks post-treatment (SVR12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crow's feet visual score variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Nasolabial folds visual score variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Skin dryness clinical score variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Physiological variables (i.e. ventilation pressures and oxygenation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Fasting HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Fasting HDL Cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in Fasting LDL Cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total Cholesterol Change From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cumulative response (4R75%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores on perceived caregiver burden
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Sensor accuracy errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of xanthohumol and metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-Day All-Cause Mortality
Endpoint domain: Mortality/survival
Primary endpoint: 30-Day Postoperative Myocardial Infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of time in the target anticoagulation range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total dosis of rFSH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in inspiratory:expiratory mean lung density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Treatment Efficacy Determined by DSAP-GASI Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of Coronoid Lamella on Dermoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Actinic Keratosis Field Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Therapeutic response (tumor size)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: refractive stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: State of fatigue management
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change From Pretreatment in Weekly Normalized Spontaneous Bowel Movement Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Global Aesthetics Improvement Scale (GAIS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in time spent in hypoglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peak Plasma concentration (Cmax) of MGCD265
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in Patient quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Patient quality of decision
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of physician visits and diagnostic tests
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in Primary symptom (cough)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Primary symptom (Fever)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time for Negative COVID-19 Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Limitations in Hand Function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maximum Plasma Concentration (Cmax) of Oseltamivir in HD Participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve (AUC) of Oseltamivir in HD Participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in effusion grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: osteonecrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Safety of combination therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Change in ICARS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Heroin Craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects with abnormal values for blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Red Blood Cell Stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maximum tolerated dose of Doxil in combination with PSC 833
Endpoint domain: Adverse events/effects
Primary endpoint: Dose limiting toxicity of Doxil in combination with PSC 833
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of adverse events and adverse drug reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Tear Sample Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of the Four Food Elimination Diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of isoproterenol-stimulated lipolysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in AVM volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conners Adult ADHD Rating Scale - Short Version (CAARS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behavior Rating Inventory of Executive Function - Adult (BRIEF-A)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Response Rate (CR+PR) at Week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Serum Adalimumab Concentration at Week 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical and anatomical healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of antinib
Endpoint domain: Adverse events/effects
Primary endpoint: Closing volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Anatomic correlation between largest Ts and site of longest delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tendon Connective Tissue Stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Skeletal Muscle Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Patellar Tendon Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of endothelial progenitor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Binocular Defocus VA at Month 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intraoperative Opioid Administration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Postoperative Opioid Administration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Ewing sarcoma survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Agreement Between SHAPE and Pressure Catheter Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Error Between SHAPE and Pressure Catheter Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in ADHD-RS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGI-I score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in CPT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of mutations in genes regulating pyrophosphate metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Identification of mutations in genes regulating phosphate metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Identification of mutations in genes regulating bisphosphonate metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: EPO level difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed drug concentration (Cmax) of roniciclib on Cycle 1 Day 1 (without itraconazole)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration vs. time curve from zero to infinity (AUC) of roniciclib on Cycle 1 Day 1 (without itraconazole)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed drug concentration (Cmax) of roniciclib on Cycle 1 Day 6 (with itraconazole)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration vs. time curve from zero to infinity (AUC) of roniciclib on Cycle 1 Day 6 (with itraconazole)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Target vessel related Myocardial Infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinically driven repeated target vessel revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: time in range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASD Screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Co-occurring Medical Conditions Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Clinical severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of swallowing disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: PASTOR survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood specimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemocompatibility as Shown by C5a
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hemocompatibility as Shown by Thrombin/Antithrombin Complex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hemocompatibility as Shown by Hematocrit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hemocompatibility as Shown by Hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hemocompatibility as Shown by White Cell Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in right ventricular (RV) function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of global myocardial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants With Adverse Events (AEs) and Laboratory Abnormalities Defined as Dose Limiting Toxicities (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Bone mineral density using DXA of hip and spine regions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of vertebral fractures using instant vertebral assessment mode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of patients with adverse reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients who are pain-free
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sleep Stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circadian Phase (melatonin rhythm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychomotor Vigilance Task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Composite of all strokes and non-CNS systemic embolism
Endpoint domain: Mortality/survival
Primary endpoint: Irritable Bowel Syndrome Symptom Severity Score (IBS-SSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bristol Stool Form Scale (BSFS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Survey Over Time
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in anthropometric indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral development
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Index Patients Who Received Annual Influenza Vaccine
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overall Infection Rate
Endpoint domain: Adverse events/effects
Primary endpoint: time to diagnosis of multiple sclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to disease modifying treatment initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of adherence to disease modifying treatment among MS patients
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: markers of metabolic health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fixation stability of the implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Effect on multiple myeloma cancer stem cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of Lymphoceles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Safety after administration of PEDIACEL® booster dose
Endpoint domain: Adverse events/effects
Primary endpoint: BRAF Mutation Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent of guideline adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Costs of both Implementation strategies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time-to-first Asthma Exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anginal status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Combined endpoint of cardiac death, myocardial infarction, stent thrombosis, or target lesion revascularisation
Endpoint domain: Mortality/survival
Primary endpoint: Change in Percent Improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Detection of abdominal recurrences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of AI in neonates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gross Motor Function Measure (GMFM-66) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer Assessment arm score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalization for cardiovascular cause or emergency department visit for atrial arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Amount of ciprofloxacin absorbed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Definite or probable legionellosis
Endpoint domain: Adverse events/effects
Primary endpoint: Change in naming test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Genotype for specific genes related to obesity, metabolic syndrome, and/or type 2 diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fasting serum biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hand grip strength, muscle strength of upper and lower extremities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Two minute walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Box and Blocks test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain as Measured by a Visual Analogue Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinic level percentage of patients receiving brief counseling
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinic level percentage of smokers offered referral to additional counseling
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinic level percentage of smokers offered medication
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: sputum microbiota bacterial diversity (richness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sputum microbiota bacterial diversity (Simpson's diversity index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clonidine plasma concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bloodloss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported healthy lifestyle beliefs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-reported Anxiety level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self-reported healthy lifestyle behaviors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severe (grade 3-4) acute graft versus host disease (aGVHD)
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline Assisting Hand Assessment measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Children's Hand-use Experience Questionnaire measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events leading to discontinuation of study therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically significant changes in ECG parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Clinically significant changes in low density lipoprotein (LDL)-c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of Eyes With IOP Reduction of ≥ 20%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Proportion of Cocaine Use Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Parenting Stress Index (PSI-SF) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in R interview scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Q-sort attachment scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing